- Home
- CAH vs CTVA Comparison
CAH vs CTVA Comparison
Compare CAH & CTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAH
- CTVA
- Stock Information
- Founded
- CAH 1979
- CTVA 2018
- Country
- CAH United States
- CTVA United States
- Employees
- CAH N/A
- CTVA 22000
- Industry
- CAH Other Pharmaceuticals
- CTVA Farming/Seeds/Milling
- Sector
- CAH Health Care
- CTVA Consumer Staples
- Exchange
- CAH Nasdaq
- CTVA Nasdaq
- Market Cap
- CAH 36.4B
- CTVA 42.1B
- IPO Year
- CAH N/A
- CTVA N/A
- Fundamental
- Price
- CAH $197.16
- CTVA $64.33
- Analyst Decision
- CAH Buy
- CTVA Strong Buy
- Analyst Count
- CAH 11
- CTVA 17
- Target Price
- CAH $193.09
- CTVA $77.81
- AVG Volume (30 Days)
- CAH 2.3M
- CTVA 4.4M
- Earning Date
- CAH 10-30-2025
- CTVA 11-04-2025
- Dividend Yield
- CAH 1.05%
- CTVA 1.16%
- EPS Growth
- CAH 27.25
- CTVA 60.76
- EPS
- CAH 6.63
- CTVA 2.03
- Revenue
- CAH $234,310,000,000.00
- CTVA $17,177,000,000.00
- Revenue This Year
- CAH $15.26
- CTVA $6.19
- Revenue Next Year
- CAH $8.34
- CTVA $3.44
- P/E Ratio
- CAH $29.48
- CTVA $29.30
- Revenue Growth
- CAH 4.39
- CTVA 1.63
- 52 Week Low
- CAH $110.63
- CTVA $53.40
- 52 Week High
- CAH $197.67
- CTVA $77.41
- Technical
- Relative Strength Index (RSI)
- CAH 86.48
- CTVA 51.31
- Support Level
- CAH $188.15
- CTVA $60.54
- Resistance Level
- CAH $197.67
- CTVA $64.56
- Average True Range (ATR)
- CAH 4.56
- CTVA 1.03
- MACD
- CAH 3.94
- CTVA 0.37
- Stochastic Oscillator
- CAH 93.23
- CTVA 84.40
About CAH Cardinal Health Inc.
Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
About CTVA Corteva Inc.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva plans to spin off its seeds business in 2026 and will become a pure-play crop protection company following the divestiture. Corteva operates globally, but around half of revenue comes from North America.